Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUYPS-1 in healthy volunteers
NCT05983328Phase 1Completed
- Sponsor
- Sinew Pharma
- Start
- May 2016
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of HUYPS-1 in Nonalcoholic steatohepatitis (NASH), sponsored by Sinew Pharma. Primary endpoint: Number of Participants With Adverse Events and Serious Adverse Events at 24 hours. Started May 2016; status: completed.
02
Drugs
HUYPS-1
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05983328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983328.